Analyst Ratings for CoLucid Pharmaceuticals (CLCD)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/23/2017 | Barclays | N/A | Downgrade | Equalweight (Overweight) |
45.00 (N/A) |
46.30 (46.53) |
0.5% | Details |
| 1/18/2017 | William Blair | N/A | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
34.90 (46.53) |
33.32% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


